Skip to content
Tenfell
Awarded contract
Published 24 Apr 2024

NHS National Framework for Transition products commencing 1 May 2024

NHS England · London

Key facts

Awarded
17 Apr 2024
Procedure
Open procedure (framework)
Buyer type
Central government

Awarded to 12 suppliers

SupplierValue
Kent Pharma Ltd—
Celix Pharma Ltd.—
Dr Reddy's Laboratories (UK) Ltd—
Thornton & Ross Ltd—
Mylan—
Sandoz Ltd—
Immedica Pharma AB—
Aspire Pharma Ltd—
Teva UK Ltd—
Glenmark Pharmaceuticals Europe Ltd—
Selective Supplies Ltd—
LogixX Pharma Ltd—

Description

Project title: NHS National Framework for Transition products commencing 1 May 2024 Offer reference number: CM/TNS/05/2024 Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months. Potential periods of call-offs under the framework agreement:

CM/TNS/05/2024/01 Lot 1 NWLN: 01/05/2024 to 31/01/2025 (9 months) Lot 2 CESW: 01/05/2024 to 30/09/2025 (17 months) Lot 3 LSNE: 01/05/2024 to 30/09/2025 (17 months)

CM/TNS/05/2024/02 Lot 1 DNW+DNE+DCE 01/05/2024 to 30/09/2025 (17 months) Lot 2 DLS+DLN+DSW 01/05/2024 to 30/09/2025 (17 months)

Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.